阿科提胺在患有功能性消化不良的儿科患者中的有效性
Keinosuke Hizuka1, Shin-Ichiro Hagiwara1, Ryutaro Saura1
1Department of Gastroenterology, Nutrition, and Endocrinology, Osaka Women's and Children's Hospital, Osaka, Japan.
Pediatric gastroenterology, hepatology & nutrition
|May 21, 2025
概括
阿可胺在治疗儿科功能性消化不良 (FD) 中表现出有效性,超过一半的年轻患者经历了症状缓解. 这种药物对于所有亚型的FD儿童可能是一个有价值的选择.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 功能性消化不良 (FD) 是一种常见的慢性腹部上部疾病,没有明确的有机原因.
- 阿科提胺是成人FD的有效治疗方法,但它的儿科疗效尚未得到充分证实.
研究的目的:
- 评估在被诊断患有功能性消化不良的儿科患者中阿科提胺的疗效.
- 确定阿科提胺是否是患有FD症状的儿童可行的治疗选择.
主要方法:
- 对33名儿童患者 (<16岁) 进行了回顾性分析,这些患者接受了阿科蒂亚米德治疗.
- 2013年8月至2022年3月期间,从一个儿童医院收集了数据.
主要成果:
- 在Acotiamide治疗一个月后,57.6%的儿科患者注意到症状改善.
- 改善率因FD亚型 (表胃疼痛综合征,食后应急综合征,重叠) 不同,但差异没有统计学意义 (p=0.213).
- 两名患者因腹部疼痛而停止治疗;没有报告严重不良事件.
结论:
- 阿科提胺在儿科功能性消化不良方面表现出有效性,反映了成年人研究结果.
- 阿科提胺为儿科FD提供了一个潜在的治疗选择,适用于其各种亚型.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
231
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
231
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
201
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
201
Drugs for Treatment of Diarrhea-Predominant IBS
133
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
133
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
153
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
153
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
383
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
383


